nodes	percent_of_prediction	percent_of_DWPC	metapath
Amphetamine—MAOB—autistic disorder	0.479	0.689	CbGaD
Amphetamine—SLC6A4—autistic disorder	0.217	0.311	CbGaD
Amphetamine—CARTPT—telencephalic ventricle—autistic disorder	0.0166	0.138	CbGeAlD
Amphetamine—CARTPT—hindbrain—autistic disorder	0.00783	0.0651	CbGeAlD
Amphetamine—SLC18A2—telencephalic ventricle—autistic disorder	0.00563	0.0469	CbGeAlD
Amphetamine—CARTPT—brainstem—autistic disorder	0.00449	0.0373	CbGeAlD
Amphetamine—CARTPT—forebrain—autistic disorder	0.00433	0.036	CbGeAlD
Amphetamine—SLC6A3—telencephalic ventricle—autistic disorder	0.00426	0.0355	CbGeAlD
Amphetamine—CARTPT—telencephalon—autistic disorder	0.00398	0.0331	CbGeAlD
Amphetamine—DRD2—telencephalic ventricle—autistic disorder	0.00313	0.0261	CbGeAlD
Amphetamine—CARTPT—head—autistic disorder	0.00248	0.0206	CbGeAlD
Amphetamine—CARTPT—nervous system—autistic disorder	0.00235	0.0196	CbGeAlD
Amphetamine—TAAR1—nervous system—autistic disorder	0.00235	0.0196	CbGeAlD
Amphetamine—CARTPT—central nervous system—autistic disorder	0.00226	0.0188	CbGeAlD
Amphetamine—TAAR1—central nervous system—autistic disorder	0.00226	0.0188	CbGeAlD
Amphetamine—CARTPT—cerebellum—autistic disorder	0.00221	0.0184	CbGeAlD
Amphetamine—SLC6A3—hindbrain—autistic disorder	0.00201	0.0167	CbGeAlD
Amphetamine—SLC6A4—hindbrain—autistic disorder	0.00184	0.0153	CbGeAlD
Amphetamine—CARTPT—brain—autistic disorder	0.0018	0.0149	CbGeAlD
Amphetamine—MAOB—hindbrain—autistic disorder	0.00175	0.0146	CbGeAlD
Amphetamine—SLC22A3—mouth—autistic disorder	0.00166	0.0138	CbGeAlD
Amphetamine—SLC18A2—brainstem—autistic disorder	0.00152	0.0127	CbGeAlD
Amphetamine—DRD2—hindbrain—autistic disorder	0.00148	0.0123	CbGeAlD
Amphetamine—SLC18A2—forebrain—autistic disorder	0.00147	0.0122	CbGeAlD
Amphetamine—SLC18A2—telencephalon—autistic disorder	0.00135	0.0113	CbGeAlD
Amphetamine—SLC6A3—brainstem—autistic disorder	0.00115	0.00959	CbGeAlD
Amphetamine—SLC6A3—forebrain—autistic disorder	0.00111	0.00926	CbGeAlD
Amphetamine—SLC6A4—brainstem—autistic disorder	0.00106	0.00879	CbGeAlD
Amphetamine—SLC18A2—digestive system—autistic disorder	0.00103	0.00859	CbGeAlD
Amphetamine—SLC6A3—telencephalon—autistic disorder	0.00102	0.00851	CbGeAlD
Amphetamine—SLC6A4—forebrain—autistic disorder	0.00102	0.00848	CbGeAlD
Amphetamine—MAOB—brainstem—autistic disorder	0.001	0.00836	CbGeAlD
Amphetamine—MAOB—forebrain—autistic disorder	0.00097	0.00807	CbGeAlD
Amphetamine—SLC6A4—telencephalon—autistic disorder	0.000938	0.0078	CbGeAlD
Amphetamine—SLC6A2—brainstem—autistic disorder	0.00093	0.00774	CbGeAlD
Amphetamine—SLC6A2—forebrain—autistic disorder	0.000898	0.00747	CbGeAlD
Amphetamine—MAOB—telencephalon—autistic disorder	0.000891	0.00742	CbGeAlD
Amphetamine—CYP2D6—hindbrain—autistic disorder	0.000889	0.00739	CbGeAlD
Amphetamine—DRD2—brainstem—autistic disorder	0.000848	0.00705	CbGeAlD
Amphetamine—SLC18A2—head—autistic disorder	0.000842	0.00701	CbGeAlD
Amphetamine—SLC6A2—telencephalon—autistic disorder	0.000826	0.00687	CbGeAlD
Amphetamine—DRD2—eye—autistic disorder	0.000825	0.00687	CbGeAlD
Amphetamine—DRD2—forebrain—autistic disorder	0.000818	0.00681	CbGeAlD
Amphetamine—SLC18A2—nervous system—autistic disorder	0.000799	0.00664	CbGeAlD
Amphetamine—SLC18A2—central nervous system—autistic disorder	0.000769	0.0064	CbGeAlD
Amphetamine—DRD2—telencephalon—autistic disorder	0.000752	0.00626	CbGeAlD
Amphetamine—SLC18A2—cerebellum—autistic disorder	0.000752	0.00625	CbGeAlD
Amphetamine—SLC6A4—digestive system—autistic disorder	0.000716	0.00595	CbGeAlD
Amphetamine—MAOB—digestive system—autistic disorder	0.000681	0.00566	CbGeAlD
Amphetamine—CYP2A6—cerebellum—autistic disorder	0.000671	0.00558	CbGeAlD
Amphetamine—Pargyline—MAOB—autistic disorder	0.000656	0.0955	CrCbGaD
Amphetamine—SLC6A3—head—autistic disorder	0.000637	0.0053	CbGeAlD
Amphetamine—Phenelzine—ABAT—autistic disorder	0.000617	0.0898	CrCbGaD
Amphetamine—SLC18A2—brain—autistic disorder	0.00061	0.00508	CbGeAlD
Amphetamine—SLC6A3—nervous system—autistic disorder	0.000604	0.00503	CbGeAlD
Amphetamine—SLC22A3—head—autistic disorder	0.0006	0.00499	CbGeAlD
Amphetamine—SLC6A4—head—autistic disorder	0.000584	0.00486	CbGeAlD
Amphetamine—SLC6A3—central nervous system—autistic disorder	0.000582	0.00484	CbGeAlD
Amphetamine—SLC22A3—nervous system—autistic disorder	0.000569	0.00473	CbGeAlD
Amphetamine—SLC6A3—cerebellum—autistic disorder	0.000568	0.00473	CbGeAlD
Amphetamine—Pseudoephedrine—IL2—autistic disorder	0.000559	0.0813	CrCbGaD
Amphetamine—MAOB—head—autistic disorder	0.000555	0.00462	CbGeAlD
Amphetamine—SLC6A4—nervous system—autistic disorder	0.000554	0.00461	CbGeAlD
Amphetamine—SLC22A3—central nervous system—autistic disorder	0.000548	0.00456	CbGeAlD
Amphetamine—CYP2A6—brain—autistic disorder	0.000545	0.00454	CbGeAlD
Amphetamine—SLC22A5—digestive system—autistic disorder	0.000535	0.00445	CbGeAlD
Amphetamine—SLC6A4—central nervous system—autistic disorder	0.000533	0.00443	CbGeAlD
Amphetamine—MAOB—nervous system—autistic disorder	0.000526	0.00438	CbGeAlD
Amphetamine—SLC6A2—head—autistic disorder	0.000514	0.00428	CbGeAlD
Amphetamine—CYP2D6—brainstem—autistic disorder	0.000509	0.00424	CbGeAlD
Amphetamine—MAOB—central nervous system—autistic disorder	0.000507	0.00422	CbGeAlD
Amphetamine—MAOB—cerebellum—autistic disorder	0.000495	0.00412	CbGeAlD
Amphetamine—CYP2D6—forebrain—autistic disorder	0.000492	0.00409	CbGeAlD
Amphetamine—SLC6A2—nervous system—autistic disorder	0.000487	0.00405	CbGeAlD
Amphetamine—SLC6A2—central nervous system—autistic disorder	0.000469	0.0039	CbGeAlD
Amphetamine—DRD2—head—autistic disorder	0.000468	0.0039	CbGeAlD
Amphetamine—SLC6A3—brain—autistic disorder	0.000462	0.00384	CbGeAlD
Amphetamine—Pargyline—MAOA—autistic disorder	0.00046	0.0669	CrCbGaD
Amphetamine—CYP2D6—telencephalon—autistic disorder	0.000452	0.00376	CbGeAlD
Amphetamine—DRD2—nervous system—autistic disorder	0.000444	0.00369	CbGeAlD
Amphetamine—SLC22A3—brain—autistic disorder	0.000435	0.00362	CbGeAlD
Amphetamine—DRD2—central nervous system—autistic disorder	0.000428	0.00356	CbGeAlD
Amphetamine—SLC6A4—brain—autistic disorder	0.000423	0.00352	CbGeAlD
Amphetamine—Tranylcypromine—MAOB—autistic disorder	0.000423	0.0615	CrCbGaD
Amphetamine—DRD2—cerebellum—autistic disorder	0.000418	0.00348	CbGeAlD
Amphetamine—MAOB—brain—autistic disorder	0.000402	0.00335	CbGeAlD
Amphetamine—SLC22A5—cerebellum—autistic disorder	0.000389	0.00324	CbGeAlD
Amphetamine—SLC6A2—brain—autistic disorder	0.000373	0.0031	CbGeAlD
Amphetamine—Phentermine—MAOB—autistic disorder	0.000354	0.0516	CrCbGaD
Amphetamine—CYP2D6—digestive system—autistic disorder	0.000345	0.00287	CbGeAlD
Amphetamine—DRD2—brain—autistic disorder	0.000339	0.00282	CbGeAlD
Amphetamine—Selegiline—MAOB—autistic disorder	0.000328	0.0477	CrCbGaD
Amphetamine—SLC22A5—brain—autistic disorder	0.000316	0.00263	CbGeAlD
Amphetamine—Tranylcypromine—MAOA—autistic disorder	0.000296	0.0431	CrCbGaD
Amphetamine—Phenelzine—MAOB—autistic disorder	0.000289	0.042	CrCbGaD
Amphetamine—CYP2D6—head—autistic disorder	0.000281	0.00234	CbGeAlD
Amphetamine—Phenylpropanolamine—MAOA—autistic disorder	0.000279	0.0406	CrCbGaD
Amphetamine—CYP2D6—nervous system—autistic disorder	0.000267	0.00222	CbGeAlD
Amphetamine—CYP2D6—central nervous system—autistic disorder	0.000257	0.00214	CbGeAlD
Amphetamine—Phenylpropanolamine—DRD1—autistic disorder	0.000253	0.0369	CrCbGaD
Amphetamine—Methamphetamine—MAOB—autistic disorder	0.000252	0.0367	CrCbGaD
Amphetamine—CYP2D6—cerebellum—autistic disorder	0.000251	0.00209	CbGeAlD
Amphetamine—Phentermine—MAOA—autistic disorder	0.000248	0.0362	CrCbGaD
Amphetamine—Pseudoephedrine—MAOA—autistic disorder	0.000235	0.0343	CrCbGaD
Amphetamine—Selegiline—MAOA—autistic disorder	0.00023	0.0335	CrCbGaD
Amphetamine—Ephedrine—ADRB2—autistic disorder	0.000221	0.0321	CrCbGaD
Amphetamine—CYP2D6—brain—autistic disorder	0.000204	0.0017	CbGeAlD
Amphetamine—Phenelzine—MAOA—autistic disorder	0.000202	0.0295	CrCbGaD
Amphetamine—Phenylpropanolamine—ADRB2—autistic disorder	0.000198	0.0288	CrCbGaD
Amphetamine—Methamphetamine—MAOA—autistic disorder	0.000177	0.0258	CrCbGaD
Amphetamine—Pseudoephedrine—ADRB2—autistic disorder	0.000167	0.0243	CrCbGaD
Amphetamine—Phentermine—SLC6A4—autistic disorder	0.00016	0.0233	CrCbGaD
Amphetamine—Pseudoephedrine—SLC6A4—autistic disorder	0.000152	0.0221	CrCbGaD
Amphetamine—Methamphetamine—SLC6A4—autistic disorder	0.000114	0.0166	CrCbGaD
Amphetamine—TAAR1—Signaling Pathways—MEF2C—autistic disorder	2.69e-05	0.000152	CbGpPWpGaD
Amphetamine—SLC18A2—Transmission across Chemical Synapses—HRAS—autistic disorder	2.68e-05	0.000151	CbGpPWpGaD
Amphetamine—CYP2D6—Biological oxidations—GSTM1—autistic disorder	2.63e-05	0.000148	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—ITGB3—autistic disorder	2.62e-05	0.000148	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—GRM8—autistic disorder	2.6e-05	0.000147	CbGpPWpGaD
Amphetamine—CYP2D6—Metapathway biotransformation—GSTM1—autistic disorder	2.59e-05	0.000146	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—SERPINE1—autistic disorder	2.57e-05	0.000145	CbGpPWpGaD
Amphetamine—SLC18A2—Neuronal System—MAPK1—autistic disorder	2.56e-05	0.000144	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ASMT—autistic disorder	2.52e-05	0.000142	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GSTM5—autistic disorder	2.52e-05	0.000142	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—AVPR1A—autistic disorder	2.52e-05	0.000142	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—WNT2—autistic disorder	2.52e-05	0.000142	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—TPH2—autistic disorder	2.51e-05	0.000142	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—POMC—autistic disorder	2.48e-05	0.00014	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—DPYD—autistic disorder	2.47e-05	0.000139	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—DHFR—autistic disorder	2.47e-05	0.000139	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—autistic disorder	2.47e-05	0.000139	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—AVP—autistic disorder	2.46e-05	0.000139	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ACADSB—autistic disorder	2.46e-05	0.000139	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—INPP1—autistic disorder	2.46e-05	0.000139	CbGpPWpGaD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—IL6—autistic disorder	2.45e-05	0.000138	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—HTR2A—autistic disorder	2.45e-05	0.000138	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—IL2—autistic disorder	2.44e-05	0.000138	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PDE4A—autistic disorder	2.44e-05	0.000138	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—VIP—autistic disorder	2.43e-05	0.000137	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—GRM5—autistic disorder	2.43e-05	0.000137	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—ADRB2—autistic disorder	2.41e-05	0.000136	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—SLC25A12—autistic disorder	2.37e-05	0.000134	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—OXTR—autistic disorder	2.36e-05	0.000133	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—SCT—autistic disorder	2.33e-05	0.000132	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—TSC2—autistic disorder	2.32e-05	0.000131	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—SLC19A1—autistic disorder	2.3e-05	0.00013	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—CACNA1C—autistic disorder	2.3e-05	0.00013	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—AVPR1A—autistic disorder	2.29e-05	0.000129	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—LEP—autistic disorder	2.27e-05	0.000128	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—APOE—autistic disorder	2.27e-05	0.000128	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NRP2—autistic disorder	2.27e-05	0.000128	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—AVP—autistic disorder	2.26e-05	0.000128	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—GABBR1—autistic disorder	2.22e-05	0.000125	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—ADM—autistic disorder	2.22e-05	0.000125	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—GRM5—autistic disorder	2.21e-05	0.000125	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—VIP—autistic disorder	2.21e-05	0.000125	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—BTD—autistic disorder	2.19e-05	0.000124	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—AVP—autistic disorder	2.18e-05	0.000123	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HTR5A—autistic disorder	2.18e-05	0.000123	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PDE4B—autistic disorder	2.17e-05	0.000122	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—PRKCB—autistic disorder	2.14e-05	0.000121	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—OXTR—autistic disorder	2.14e-05	0.000121	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—SCT—autistic disorder	2.12e-05	0.000119	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—OPRM1—autistic disorder	2.1e-05	0.000118	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—DHFR—autistic disorder	2.09e-05	0.000118	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ADSL—autistic disorder	2.05e-05	0.000116	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—APC—autistic disorder	2.05e-05	0.000116	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—PIK3CG—autistic disorder	2.05e-05	0.000116	CbGpPWpGaD
Amphetamine—SLC18A2—Neuronal System—HRAS—autistic disorder	2.05e-05	0.000116	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—EGF—autistic disorder	2.03e-05	0.000114	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—ADM—autistic disorder	2.02e-05	0.000114	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—GABBR1—autistic disorder	2.02e-05	0.000114	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—XDH—autistic disorder	2.01e-05	0.000114	CbGpPWpGaD
Amphetamine—SLC6A4—Circadian rythm related genes—IL6—autistic disorder	2e-05	0.000113	CbGpPWpGaD
Amphetamine—SLC6A3—Transmission across Chemical Synapses—MAPK1—autistic disorder	1.99e-05	0.000112	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—STX1A—autistic disorder	1.98e-05	0.000111	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—NPAS2—autistic disorder	1.98e-05	0.000111	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—autistic disorder	1.97e-05	0.000111	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PDE4B—autistic disorder	1.97e-05	0.000111	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—PTEN—autistic disorder	1.96e-05	0.00011	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—POMC—autistic disorder	1.95e-05	0.00011	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—CYP19A1—autistic disorder	1.94e-05	0.000109	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—TCN2—autistic disorder	1.91e-05	0.000108	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—OPRM1—autistic disorder	1.91e-05	0.000108	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—HTR2A—autistic disorder	1.88e-05	0.000106	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—IGF1—autistic disorder	1.88e-05	0.000106	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—MAPK1—autistic disorder	1.87e-05	0.000105	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—HTR1B—autistic disorder	1.86e-05	0.000105	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—OXT—autistic disorder	1.86e-05	0.000105	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—TDO2—autistic disorder	1.86e-05	0.000105	CbGpPWpGaD
Amphetamine—CYP2D6—Biological oxidations—POMC—autistic disorder	1.86e-05	0.000105	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—GABBR2—autistic disorder	1.85e-05	0.000104	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ADA—autistic disorder	1.82e-05	0.000103	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—COMT—autistic disorder	1.8e-05	0.000101	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—GSTP1—autistic disorder	1.79e-05	0.000101	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—MAOA—autistic disorder	1.79e-05	0.000101	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—SERPINE1—autistic disorder	1.78e-05	0.000101	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—DHCR7—autistic disorder	1.75e-05	9.89e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—CAT—autistic disorder	1.74e-05	9.83e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—DRD1—autistic disorder	1.73e-05	9.78e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—HTR1B—autistic disorder	1.69e-05	9.55e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—OXT—autistic disorder	1.69e-05	9.55e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—DRD3—autistic disorder	1.68e-05	9.47e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—EXT1—autistic disorder	1.66e-05	9.37e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—SLC6A8—autistic disorder	1.66e-05	9.37e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—RORA—autistic disorder	1.66e-05	9.37e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HTR1D—autistic disorder	1.65e-05	9.31e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—GSTM1—autistic disorder	1.65e-05	9.28e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PLA2G4A—autistic disorder	1.65e-05	9.28e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—IL5—autistic disorder	1.64e-05	9.27e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—CYP19A1—autistic disorder	1.64e-05	9.24e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CALCA—autistic disorder	1.62e-05	9.15e-05	CbGpPWpGaD
Amphetamine—SLC6A3—Transmission across Chemical Synapses—HRAS—autistic disorder	1.6e-05	9e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PRLR—autistic disorder	1.59e-05	8.96e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—DAO—autistic disorder	1.58e-05	8.94e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—GPX1—autistic disorder	1.58e-05	8.89e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—DRD1—autistic disorder	1.57e-05	8.88e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—MAOB—autistic disorder	1.56e-05	8.78e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—GRM8—autistic disorder	1.53e-05	8.66e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—DRD3—autistic disorder	1.52e-05	8.6e-05	CbGpPWpGaD
Amphetamine—SLC6A3—Neuronal System—MAPK1—autistic disorder	1.52e-05	8.59e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—COMT—autistic disorder	1.52e-05	8.59e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—UPB1—autistic disorder	1.52e-05	8.57e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—GSTP1—autistic disorder	1.52e-05	8.55e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—MAOA—autistic disorder	1.51e-05	8.53e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—POMC—autistic disorder	1.5e-05	8.48e-05	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—HRAS—autistic disorder	1.5e-05	8.47e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—IL5—autistic disorder	1.49e-05	8.42e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—WNT2—autistic disorder	1.49e-05	8.38e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—CAT—autistic disorder	1.47e-05	8.32e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CALCA—autistic disorder	1.47e-05	8.31e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—GHR—autistic disorder	1.46e-05	8.26e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—MTHFR—autistic disorder	1.45e-05	8.2e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—TPH2—autistic disorder	1.45e-05	8.16e-05	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—IL2—autistic disorder	1.44e-05	8.14e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PDE4A—autistic disorder	1.44e-05	8.14e-05	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—IL6—autistic disorder	1.44e-05	8.1e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—DPYD—autistic disorder	1.42e-05	8.03e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ASMT—autistic disorder	1.41e-05	7.97e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GSTM5—autistic disorder	1.41e-05	7.97e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PLA2G4A—autistic disorder	1.39e-05	7.85e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—GSTM1—autistic disorder	1.39e-05	7.85e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—ADRB2—autistic disorder	1.36e-05	7.67e-05	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—PTEN—autistic disorder	1.36e-05	7.66e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—APOE—autistic disorder	1.35e-05	7.64e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—AVPR1A—autistic disorder	1.35e-05	7.62e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—GPX1—autistic disorder	1.33e-05	7.52e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—SLC25A12—autistic disorder	1.33e-05	7.49e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CACNA1C—autistic disorder	1.32e-05	7.46e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—VIP—autistic disorder	1.3e-05	7.36e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—GRM5—autistic disorder	1.3e-05	7.36e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—SLC19A1—autistic disorder	1.29e-05	7.29e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—AVP—autistic disorder	1.28e-05	7.21e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—OXTR—autistic disorder	1.26e-05	7.13e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SCT—autistic disorder	1.25e-05	7.06e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—ADRB2—autistic disorder	1.24e-05	6.97e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—MTHFR—autistic disorder	1.23e-05	6.94e-05	CbGpPWpGaD
Amphetamine—SLC6A3—Neuronal System—HRAS—autistic disorder	1.22e-05	6.9e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PIK3CG—autistic disorder	1.22e-05	6.89e-05	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—IL6—autistic disorder	1.22e-05	6.89e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—DHFR—autistic disorder	1.2e-05	6.79e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ADM—autistic disorder	1.19e-05	6.73e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—GABBR1—autistic disorder	1.19e-05	6.73e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—EIF4E—autistic disorder	1.17e-05	6.62e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—POMC—autistic disorder	1.16e-05	6.56e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PDE4B—autistic disorder	1.16e-05	6.56e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—AVP—autistic disorder	1.16e-05	6.55e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ADSL—autistic disorder	1.15e-05	6.5e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—APOE—autistic disorder	1.15e-05	6.46e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—XDH—autistic disorder	1.13e-05	6.37e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—OPRM1—autistic disorder	1.13e-05	6.35e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—STX1A—autistic disorder	1.11e-05	6.25e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—NPAS2—autistic disorder	1.11e-05	6.25e-05	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—MAPK1—autistic disorder	1.1e-05	6.23e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PLA2G4A—autistic disorder	1.09e-05	6.15e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—TCN2—autistic disorder	1.07e-05	6.04e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—HTR2A—autistic disorder	1.06e-05	6e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PIK3CG—autistic disorder	1.03e-05	5.83e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—GZMB—autistic disorder	1.03e-05	5.81e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ADA—autistic disorder	1.02e-05	5.76e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HTR1B—autistic disorder	1e-05	5.64e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—OXT—autistic disorder	1e-05	5.64e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—POMC—autistic disorder	9.84e-06	5.55e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—HTR2A—autistic disorder	9.66e-06	5.45e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CYP19A1—autistic disorder	9.43e-06	5.32e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PRKCB—autistic disorder	9.32e-06	5.26e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—RORA—autistic disorder	9.31e-06	5.25e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TSC1—autistic disorder	9.3e-06	5.24e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—DRD1—autistic disorder	9.3e-06	5.24e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PTGS2—autistic disorder	9.28e-06	5.23e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NTRK2—autistic disorder	9.04e-06	5.1e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—DRD3—autistic disorder	9e-06	5.08e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PIK3CG—autistic disorder	8.92e-06	5.03e-05	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—HRAS—autistic disorder	8.87e-06	5e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IL5—autistic disorder	8.81e-06	4.97e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—COMT—autistic disorder	8.77e-06	4.94e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—MAOB—autistic disorder	8.73e-06	4.92e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GSTP1—autistic disorder	8.72e-06	4.92e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CALCA—autistic disorder	8.71e-06	4.91e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—MAOA—autistic disorder	8.7e-06	4.91e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—POMC—autistic disorder	8.49e-06	4.79e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CAT—autistic disorder	8.49e-06	4.79e-05	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—IL6—autistic disorder	8.49e-06	4.79e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PRKCB—autistic disorder	8.46e-06	4.77e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—TPH2—autistic disorder	8.11e-06	4.58e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PIK3CG—autistic disorder	8.1e-06	4.57e-05	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PTEN—autistic disorder	8.09e-06	4.56e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GSTM1—autistic disorder	8.02e-06	4.52e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PLA2G4A—autistic disorder	8.02e-06	4.52e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—DPYD—autistic disorder	7.98e-06	4.5e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PTGS2—autistic disorder	7.85e-06	4.43e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—POMC—autistic disorder	7.71e-06	4.35e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PRL—autistic disorder	7.69e-06	4.34e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GPX1—autistic disorder	7.68e-06	4.33e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CACNA1C—autistic disorder	7.42e-06	4.19e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ADRB2—autistic disorder	7.3e-06	4.12e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—MTHFR—autistic disorder	7.09e-06	4e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—AVP—autistic disorder	6.85e-06	3.87e-05	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PTEN—autistic disorder	6.85e-06	3.86e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IGF2—autistic disorder	6.82e-06	3.85e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—DHFR—autistic disorder	6.75e-06	3.81e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—APOE—autistic disorder	6.6e-06	3.72e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PLA2G4A—autistic disorder	6.44e-06	3.64e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—IL2—autistic disorder	6.28e-06	3.54e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MEF2C—autistic disorder	6.27e-06	3.54e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ITGB3—autistic disorder	6.11e-06	3.45e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PIK3CG—autistic disorder	5.95e-06	3.36e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HTR2A—autistic disorder	5.7e-06	3.22e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—IL2—autistic disorder	5.7e-06	3.22e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—POMC—autistic disorder	5.67e-06	3.2e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TSC2—autistic disorder	5.42e-06	3.06e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—APOE—autistic disorder	5.3e-06	2.99e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—LEP—autistic disorder	5.3e-06	2.99e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CYP19A1—autistic disorder	5.29e-06	2.98e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PRKCB—autistic disorder	5e-06	2.82e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—COMT—autistic disorder	4.92e-06	2.77e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GSTP1—autistic disorder	4.89e-06	2.76e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—MAOA—autistic disorder	4.88e-06	2.75e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PIK3CG—autistic disorder	4.79e-06	2.7e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—APC—autistic disorder	4.79e-06	2.7e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CAT—autistic disorder	4.76e-06	2.69e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—EGF—autistic disorder	4.73e-06	2.67e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—POMC—autistic disorder	4.56e-06	2.57e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PTGS2—autistic disorder	4.52e-06	2.55e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PLA2G4A—autistic disorder	4.5e-06	2.54e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GSTM1—autistic disorder	4.5e-06	2.54e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IGF1—autistic disorder	4.38e-06	2.47e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—MAPK1—autistic disorder	4.36e-06	2.46e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GPX1—autistic disorder	4.31e-06	2.43e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SERPINE1—autistic disorder	4.16e-06	2.35e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—MTHFR—autistic disorder	3.97e-06	2.24e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PTEN—autistic disorder	3.94e-06	2.22e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—APOE—autistic disorder	3.7e-06	2.09e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—HRAS—autistic disorder	3.5e-06	1.97e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IL2—autistic disorder	3.37e-06	1.9e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—IL6—autistic disorder	3.35e-06	1.89e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PIK3CG—autistic disorder	3.34e-06	1.88e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—POMC—autistic disorder	3.18e-06	1.79e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PTEN—autistic disorder	3.17e-06	1.79e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MAPK1—autistic disorder	2.58e-06	1.45e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PTGS2—autistic disorder	2.53e-06	1.43e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PTEN—autistic disorder	2.21e-06	1.25e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HRAS—autistic disorder	2.07e-06	1.17e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IL6—autistic disorder	1.98e-06	1.12e-05	CbGpPWpGaD
